Published in Cancer Epidemiol Biomarkers Prev on February 01, 2016
Thyroid function: Thyroid dysfunction and breast cancer risk - an unfinished story. Nat Rev Endocrinol (2016) 0.75
Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer. Oncotarget (2016) 0.75
Female Reproductive Factors and Differentiated Thyroid Cancer. Front Endocrinol (Lausanne) (2017) 0.75
Investigating the association of rs2910164 with cancer in Irish patients. Endocr Connect (2017) 0.75
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg (2014) 5.18
International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control (2008) 3.72
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid (2009) 2.79
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat (2010) 2.75
Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med (2014) 2.74
Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA (2010) 2.36
Obesity as a major risk factor for cancer. J Obes (2013) 2.26
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab (2007) 2.26
Cancer of the thyroid in children: a report of 28 cases. J Clin Endocrinol Metab (1950) 2.10
Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10
Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control (1997) 1.89
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86
Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med (1995) 1.83
The Chernobyl accident--an epidemiological perspective. Clin Oncol (R Coll Radiol) (2011) 1.82
Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 1.81
Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst (1980) 1.76
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol (2009) 1.74
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab (2007) 1.71
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. Eur J Endocrinol (2006) 1.67
Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer (2005) 1.61
Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up. Dtsch Arztebl Int (2014) 1.56
Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54
Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev (2015) 1.54
The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol (1986) 1.53
Multiple primary breast and thyroid cancer. Br J Cancer (1984) 1.42
Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer (2001) 1.30
Patterns of radioiodine uptake by the lactating breast. Eur J Nucl Med (1994) 1.28
Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid (2010) 1.28
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab (2011) 1.25
Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol (2007) 1.25
Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer (2006) 1.21
Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet (2011) 1.19
The development of breast carcinoma in women with thyroid carcinoma. Cancer (2001) 1.17
Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res (1987) 1.17
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol (2013) 1.16
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene (2002) 1.15
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol (2013) 1.13
Cancer risk in women with previous breast cancer. Ann Oncol (2003) 1.13
Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13
Second cancers after breast cancer treatment. Semin Oncol (2003) 1.10
Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat (2000) 1.09
Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev (2008) 1.08
Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control (2006) 1.03
Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid (2007) 1.03
Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer (2001) 1.02
Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat (2005) 1.00
Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer (1984) 0.99
Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol (2000) 0.98
Latency period of thyroid neoplasia after radiation exposure. Ann Surg (2004) 0.97
Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res (2001) 0.97
Cancer risks in thyroid cancer patients. Br J Cancer (1991) 0.96
Second primary cancers following female breast cancer in Osaka, Japan--a population-based cohort study. Jpn J Clin Oncol (1987) 0.96
Second primary breast and thyroid cancers (Israel). Cancer Causes Control (2003) 0.95
Risk of primary non-breast cancer after female breast cancer by age at diagnosis. Cancer Epidemiol Biomarkers Prev (2011) 0.94
The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid (2013) 0.93
Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer (1997) 0.92
Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol (2013) 0.92
Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. J Clin Oncol (2014) 0.92
Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). Gynecol Oncol (2013) 0.92
The risk of multiple primary breast and thyroid carcinomas. Cancer (2003) 0.91
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. Natl Cancer Inst Monogr (1985) 0.91
Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States). Cancer Causes Control (2000) 0.90
Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol (2012) 0.90
The carcinogenic effects of radioiodine therapy for thyroid carcinoma. Nat Clin Pract Endocrinol Metab (2008) 0.88
Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett (2005) 0.88
Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer. World J Surg Oncol (2011) 0.87
A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control (1999) 0.87
Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2004) 0.86
Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies. Cancer Epidemiol Biomarkers Prev (2015) 0.84
Second primary malignancies following thyroid cancer: a population-based study in Taiwan. Eur J Endocrinol (2013) 0.83
Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Acta Oncol (1992) 0.83
Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev (2008) 0.82
Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study. Eur J Cancer (1998) 0.81
Second primary neoplasms after 19281 endocrine gland tumours: aetiological links? Eur J Cancer (2001) 0.81
Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. Cancer Res (1990) 0.81
Radiation-induced thyroid cancer: the Chicago experience. Surgery (2009) 0.80
Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett (1994) 0.79
Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol (1993) 0.78
External radiotherapy prior to thyroid cancer: a case-control study. Int J Radiat Oncol Biol Phys (1993) 0.78
Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. PLoS One (2014) 0.78
Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. Strahlenther Onkol (1992) 0.76
Multiple primary neoplasms in patients with salivary gland or thyroid gland tumors. Laryngoscope (1986) 0.76